Synchronization of cancer cell lines with methotrexate in vitro

Eugenio Erba; Soumitra Sen

doi:10.1007/BF00122166

Synchronization of cancer cell lines with methotrexate in vitro

Eugenio Erba, Soumitra Sen

Istituto di Ricerche Farmacologiche "Mario Negri"

Research output: Contribution to journal › Article

Abstract

Detailed procedure are described for inducing synchrony in cancer cell lines of human origin (Jurkat, K562, U937, SW626) and L1210 cell line of murine origin by using very low non-toxic concentrations (0.04-0.08 μM for 13-24 hours) of methotrexate under standard culture conditions. This protocol offers a method for synchronization of cells at the G₁/S boundary and through the S-G₂-M phases of the cell cycle. Kinetic behavior and biological properties of the synchronized cells are considered for characterisation of the system. Comparisons are made with MTX synchronization and that induced by aphidicolin alone or by a combination of serum deprivation and aphidicolin. Methotrexate appears to be the best choice for obtaining highly synchronous human cancer cell population without cytotoxicity or detectable physiological perturbations.

Original language	English
Pages (from-to)	149-163
Number of pages	15
Journal	Methods in Cell Science
Volume	18
Issue number	2
DOIs	https://doi.org/10.1007/BF00122166
Publication status	Published - 1996

Keywords

Cancer cell lines
Cell synchronization
Flow cytometry
MTX

ASJC Scopus subject areas

Cell Biology

Access to Document

10.1007/BF00122166

Fingerprint Dive into the research topics of 'Synchronization of cancer cell lines with methotrexate in vitro'. Together they form a unique fingerprint.

Cite this

Erba, E., & Sen, S. (1996). Synchronization of cancer cell lines with methotrexate in vitro. Methods in Cell Science, 18(2), 149-163. https://doi.org/10.1007/BF00122166

@article{d03d298f68414259a43a682fbfb53253,

title = "Synchronization of cancer cell lines with methotrexate in vitro",

abstract = "Detailed procedure are described for inducing synchrony in cancer cell lines of human origin (Jurkat, K562, U937, SW626) and L1210 cell line of murine origin by using very low non-toxic concentrations (0.04-0.08 μM for 13-24 hours) of methotrexate under standard culture conditions. This protocol offers a method for synchronization of cells at the G1/S boundary and through the S-G2-M phases of the cell cycle. Kinetic behavior and biological properties of the synchronized cells are considered for characterisation of the system. Comparisons are made with MTX synchronization and that induced by aphidicolin alone or by a combination of serum deprivation and aphidicolin. Methotrexate appears to be the best choice for obtaining highly synchronous human cancer cell population without cytotoxicity or detectable physiological perturbations.",

keywords = "Cancer cell lines, Cell synchronization, Flow cytometry, MTX",

author = "Eugenio Erba and Soumitra Sen",

year = "1996",

doi = "10.1007/BF00122166",

language = "English",

volume = "18",

pages = "149--163",

journal = "Methods in Cell Science",

issn = "1381-5741",

publisher = "Kluwer Academic Publishers",

number = "2",

}

TY - JOUR

T1 - Synchronization of cancer cell lines with methotrexate in vitro

AU - Erba, Eugenio

AU - Sen, Soumitra

PY - 1996

Y1 - 1996

N2 - Detailed procedure are described for inducing synchrony in cancer cell lines of human origin (Jurkat, K562, U937, SW626) and L1210 cell line of murine origin by using very low non-toxic concentrations (0.04-0.08 μM for 13-24 hours) of methotrexate under standard culture conditions. This protocol offers a method for synchronization of cells at the G1/S boundary and through the S-G2-M phases of the cell cycle. Kinetic behavior and biological properties of the synchronized cells are considered for characterisation of the system. Comparisons are made with MTX synchronization and that induced by aphidicolin alone or by a combination of serum deprivation and aphidicolin. Methotrexate appears to be the best choice for obtaining highly synchronous human cancer cell population without cytotoxicity or detectable physiological perturbations.

AB - Detailed procedure are described for inducing synchrony in cancer cell lines of human origin (Jurkat, K562, U937, SW626) and L1210 cell line of murine origin by using very low non-toxic concentrations (0.04-0.08 μM for 13-24 hours) of methotrexate under standard culture conditions. This protocol offers a method for synchronization of cells at the G1/S boundary and through the S-G2-M phases of the cell cycle. Kinetic behavior and biological properties of the synchronized cells are considered for characterisation of the system. Comparisons are made with MTX synchronization and that induced by aphidicolin alone or by a combination of serum deprivation and aphidicolin. Methotrexate appears to be the best choice for obtaining highly synchronous human cancer cell population without cytotoxicity or detectable physiological perturbations.

KW - Cancer cell lines

KW - Cell synchronization

KW - Flow cytometry

KW - MTX

UR - http://www.scopus.com/inward/record.url?scp=0029822880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029822880&partnerID=8YFLogxK

U2 - 10.1007/BF00122166

DO - 10.1007/BF00122166

M3 - Article

AN - SCOPUS:0029822880

VL - 18

SP - 149

EP - 163

JO - Methods in Cell Science

JF - Methods in Cell Science

SN - 1381-5741

IS - 2

ER -